4
Changes in Ownership
Whitehawk Therapeutics, Inc. Filed Acc 0001415889-25-006316
CHIEF EXECUTIVE OFFICER sold 5,690 shares at $2.35 ($13,372)
- CHIEF EXECUTIVE OFFICER acquired 16,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lennon David James CHIEF EXECUTIVE OFFICER | 2025-03-01 | Option exercise | +16,250 | 39,119 | D | ||
| Lennon David James CHIEF EXECUTIVE OFFICER | 2025-03-03 | Sale | −5,690 | $2.35 | $13,372 | 33,429 | D |
| Derivatives | |||||||
| Lennon David James CHIEF EXECUTIVE OFFICER | 2025-03-01 | Option exercise · Restricted Stock Units | −16,250 | 48,750 | D | ||
| Open-market sales · 5,690 sh · avg $2.35 · $13,372 | |||||||
Loading xslF345X05/form4-03042025_010346.xml…